Merck & Co., Inc.* donates Mectizan for the elimination of onchocerciasis as a public health problem in Africa, Latin America, and Yemen. For the elimination of lymphatic filariasis in Africa and Yemen where onchocerciasis is co-endemic, Mectizan is co-administered with albendazole, which is donated by GlaxoSmithKline. Through the generosity and commitment to improving global health and increasing access to medicines, Merck has provided more than one billion treatments for onchocerciasis and lymphatic filariasis. Both companies also provide support for program implementation where necessary.
*Merck & Co., Inc. is known as MSD outside North America.